Trials / Conditions / Erythropoietic Protoporphyria (EPP)
Erythropoietic Protoporphyria (EPP)
6 registered clinical trials studyying Erythropoietic Protoporphyria (EPP) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Study of Bitopertin in Participants With EPP or XLP (APOLLO) NCT06910358 | Disc Medicine, Inc | Phase 3 |
| Enrolling By Invitation | GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria NCT06971900 | Portal Therapeutics, Inc. | Phase 2 |
| Active Not Recruiting | INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP NCT06144840 | Tanabe Pharma America, Inc. | Phase 3 |
| Completed | Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria NCT03520036 | Tanabe Pharma America, Inc. | Phase 2 |
| Terminated | Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria NCT01550705 | University of Utah | N/A |
| Completed | Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium NCT01880983 | University of Alabama at Birmingham | — |